Navigate to Other Sector


Healthcare Newsletter – July 2017

Celebration Month for Biosimilars that also marks Indian Pharma stepping into USFDA approved zone
Indian Pharma Seeking Innovation-Centric Growth Beyond Generics
Smart Partnerships remain Crucial in POC Diagnostics space
Sanofi gets Flublok in a deal highlighting Scale up Challenges for Innovative Vaccine Ventures
Flourishing Med Tech Infrastructure Initiatives in Asia calls attention to other Looming Issues

Contact us to know more…

Discussion — No responses

Show Buttons
Hide Buttons